Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects

Conditions

• Cancer
• Bowel Dysfunction

Interventions

• DRUG: alvimopan
• DRUG: placebo

Sponsor

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Collaborators

• [object Object]